{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:09:18Z","timestamp":1784124558840,"version":"3.55.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le SIDA et les H\u00e9patites virales \u2013 Maladies Infectieuses Emergentes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent studies have shown progress in understanding the evolution of HIV antiretroviral resistance\u2013associated mutations (RAMs) in the reservoir, particularly M184V, but data on non-nucleoside reverse transcriptase (RT) inhibitors RAMs (NNRTI-RAMs) remain limited. This study aimed to describe the evolution of NNRTI-RAMs in the reservoir, with or without M184V.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This single-centre retrospective study included people living with HIV-1 (PLWHIV) who had one or more NNRTI-RAMs detected in plasma genotype, and who had blood samples collected after at least 1 year of virological suppression on antiretroviral therapy. RT NGS was performed at two time points during virological suppression: DNA1 (2019) and DNA2 (2024).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 49 PLWHIV with NNRTI-RAMs, 40 had an M184V mutation in their previous HIV-1 RNA genotypes. At DNA1, NNRTI-RAMs and M184V were present in 44.9% (n\u200a=\u200a22\/49) and 65.0% (n\u200a=\u200a26\/40) of PLWHIV, respectively. In univariate analysis, NNRTI-RAM clearance at DNA1 was associated with shorter duration of replication under an NNRTI regimen at virological failure (VF) (5 versus 37\u2005months, P\u200a=\u200a0.013), longer duration between RNA and DNA1 genotypes (14 versus 9\u2005years, P\u200a=\u200a0.010) and older age (60 versus 55\u2005years, P\u200a=\u200a0.037). Only replication duration remained associated with the persistence of NNRTI-RAMs (P\u200a=\u200a0.041) in multivariate analysis. Past M184V in RNA genotypes was not associated with NNRTI-RAM persistence at DNA1 or DNA2 (P\u200a=\u200a0.477 and P\u200a=\u200a0.711, respectively). No significant evolution of NNRTI-RAMs was observed between DNA1 and DNA2 (P\u200a&amp;gt;\u200a0.999).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In virologically suppressed PLWHIV, NNRTI-RAMs and M184V in the HIV blood reservoir decreased without evidence of interaction between their evolution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag245","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:21:41Z","timestamp":1784121701000},"source":"Crossref","is-referenced-by-count":0,"title":["Clearance of NNRTI resistance-associated mutations in the HIV-1 DNA reservoir with or without the presence of M184V mutation"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2032-4148","authenticated-orcid":false,"given":"Cathia","family":"Soulie","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, laboratoire de virologie , 45-83 bd de l\u2019h\u00f4pital, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Zafilaza","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, laboratoire de virologie , 45-83 bd de l\u2019h\u00f4pital, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3723-4142","authenticated-orcid":false,"given":"Marc","family":"Wirden","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, laboratoire de virologie , 45-83 bd de l\u2019h\u00f4pital, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Sayon","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, laboratoire de virologie , 45-83 bd de l\u2019h\u00f4pital, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-0010","authenticated-orcid":false,"given":"Basma","family":"Abdi","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, laboratoire de virologie , 45-83 bd de l\u2019h\u00f4pital, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9ophile","family":"Cocherie","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, laboratoire de virologie , 45-83 bd de l\u2019h\u00f4pital, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Teyssou","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, laboratoire de virologie , 45-83 bd de l\u2019h\u00f4pital, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Antoine","family":"Valantin","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, service de maladies infectieuses , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Faycal","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, service de maladies infectieuses , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luminita","family":"Schneider","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, service de maladies infectieuses , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3879-1480","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Pourcher","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, service de maladies infectieuses , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Calvez","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, laboratoire de virologie , 45-83 bd de l\u2019h\u00f4pital, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Genevi\u00e8ve","family":"Marcelin","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019Epid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pitaux Universitaires Piti\u00e9 Salp\u00eatri\u00e8re \u2013 Charles Foix, laboratoire de virologie , 45-83 bd de l\u2019h\u00f4pital, Paris 75013 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2026071509213534800_dkag245-B1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/17425255.2019.1673367","article-title":"Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment","volume":"15","author":"Wang","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2026071509213534800_dkag245-B2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.coph.2020.10.009","article-title":"Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens","volume":"54","author":"Vanangamudi","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"2026071509213534800_dkag245-B3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/v8100263","article-title":"Mechanistic study of common non-nucleoside reverse transcriptase inhibitor-resistant mutations with K103N and Y181C substitutions","volume":"8","author":"Lai","year":"2016","journal-title":"Viruses"},{"key":"2026071509213534800_dkag245-B4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.virusres.2007.12.018","article-title":"Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase","volume":"134","author":"Ren","year":"2008","journal-title":"Virus Res"},{"key":"2026071509213534800_dkag245-B5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/infdis\/jiab413","article-title":"Kinetics of archived M184V mutation in treatment-experienced virally suppressed HIV-infected patients","volume":"225","author":"Palich","year":"2022","journal-title":"J Infect Dis"},{"key":"2026071509213534800_dkag245-B6","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/jac\/dkaa146","article-title":"Differential detection of M184V\/I between plasma historical HIV genotypes and HIV proviral DNA from PBMCs","volume":"75","author":"Margot","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2026071509213534800_dkag245-B7","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/jac\/dky130","article-title":"Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART","volume":"73","author":"Nouchi","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026071509213534800_dkag245-B8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/jac\/dkv395","article-title":"Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression","volume":"71","author":"Gantner","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2026071509213534800_dkag245-B9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/cid\/ciaf430","article-title":"Kinetics of non-nucleoside reverse transcriptase inhibitor resistance-associated mutations in HIV-1 proviral cellular reservoirs in NNRTI-experienced persons","volume":"82","author":"Drumel","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026071509213534800_dkag245-B10","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/jac\/dkaf349","article-title":"Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO registry","volume":"80","author":"Armenia","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026071509213534800_dkag245-B11","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae194","article-title":"Clearance of archived integrase strand transfer inhibitors resistance mutations in people with virologically suppressed HIV infection","volume":"6","author":"Abdi","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2026071509213534800_dkag245-B12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12977-018-0448-8","article-title":"The role of integration and clonal expansion in HIV infection: live long and prosper","volume":"15","author":"Anderson","year":"2018","journal-title":"Retrovirology"},{"key":"2026071509213534800_dkag245-B13","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1093\/infdis\/jiw636","article-title":"Clonal expansion of human immunodeficiency virus-infected cells and human immunodeficiency virus persistence during antiretroviral therapy","volume":"215","author":"Mullins","year":"2017","journal-title":"J Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/8\/dkag245\/68882955\/dkag245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/8\/dkag245\/68882955\/dkag245.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:21:43Z","timestamp":1784121703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag245\/8734728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag245","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,2]]},"article-number":"dkag245"}}